ABBRATECH INC.
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.2Mattributed |
|---|---|
| Latest round | grant, $2.2M, 2023-09-01attributed |
| Founded | 2020 |
| Headquarters | Guilford, Connecticut, USA |
| Industry | bio |
| Stage | unknown |
| Website | abbratech.com |
AbbraTech is a biotech firm specializing in recombinant antibody discovery through its Epivolve platform. It serves pharmaceutical and academic partners developing therapeutics for cancer, immune disorders, and viral infections. Its platform reaches disease targets that conventional methods cannot, overcoming immunogenicity and immune tolerance.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-09-01 | grant | $2.2M | undisclosed |
Detected tech stack
Cloudflare, reCAPTCHA, Site Kit 1.179.0, jQuery Migrate 3.4.1, Elementor 4.0.9, Cloudflare Bot Management, WordPress, Python, PHP, MySQL, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.2M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.2M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | abbratech.com, read 2026-05-05 |
| Description | self-reported | abbratech.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.